Integrated mental health company providing solutions to develop and deliver psychedelic-assisted psychotherapy as well as transform the mental health landscape Numinus Wellness Inc. (TSXV: NUMI) announced having agreed to acquire the Neurological Center of Toronto.

The company said it entered into a purchase agreement with the neurological center on July 2 in which Numinus will pay $300,000 in cash and $200,000 in Numinus shares after closing and a future performance based payments adding up to $500,000 in of Numinus shares.

This acquisition deal will be subject to a number of conditions including a regulatory approval from the TSX venture exchange.

Numinus says that it has already finalized its due diligence and it expects that the acquisition of NCT will be closed by end of August 2021.

Leave a Reply